Watch FIFA World Cup 2026™

LIVE, FREE and EXCLUSIVE

Shortage of diphtheria meds hits Rohingya

A shortage of diphtheria medication is the latest challenge facing health workers in Rohingya refugee camps in Bangladesh with 100 new cases occurring each day.

Health workers in Rohingya refugee camps in Bangladesh are struggling with a shortage of medics able to administer antitoxins to patients infected with diphtheria that has killed nearly two dozen people.

Neighbouring Myanmar's military cracked down on Muslim Rohingya from Rakhine state following Rohingya militant attacks on an army base and police posts on August 25. More than 650,000 Rohingya have fled mainly Buddhist Myanmar to Bangladesh since August, on top of more than 200,000 who fled earlier, according to the latest United Nations data.

Doctors Without Borders (MSF), the lead agency dealing with an outbreak of the bacterial disease in camps sheltering the Rohingya, has treated around 2000 patients in the past few weeks and is receiving around 100 new cases daily.

The World Health Organisation (WHO) describes diphtheria as a widespread, severe infectious disease with epidemic potential and a mortality rate of up to 10 per cent. MSF has called diphtheria a disease "long forgotten in most parts of the world thanks to increasing rates of vaccination".

MSF has managed to provide antitoxins to only around 12 patients daily due to the lack of trained medics, said Crystal van Leeuwen, an MSF emergency medical coordinator now in Cox's Bazar where the refugee camps are located.

News that makes sense

Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

"Once we do have enough people and other organisations start to administer as well, we may get into a situation where we don't have enough antitoxins anymore," she said.

"It's a double-edged sword. We need both the human resources to administer it, and we need more antitoxins at the same time."

According to a UN report in February, supply of diphtheria antitoxin serum has been limited for many years and the shortage is expected to continue.


2 min read

Published

Source: AAP


Share this with family and friends


Get SBS News straight to your inbox

Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Follow SBS News

Download our apps

Listen to our podcasts

Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS

SBS World News

Take a global view with Australia's most comprehensive world news service

Stream now

Watch the latest news videos from Australia and across the world